Sanofi-Aventis Hungary Sanofi for 3,5 years. It must have been quite a different market, culture and environment. Yet, at that time you publicly announced that it only took you 30 seconds to accept the move. Why was this such an easy choice? In Hungary, Sanofi has a presence that reaches far beyond…
Sanofi Russia There has been quite a bit of dynamism in the domestic pharmaceutical market since Focus Reports last look at the Russian market in 2006/2007. What have been the main changes you have witnessed throughout these five years? There have been several major developments in this market. The most important has…
Sanofi Aventis Malaysia Pharmaceutical Executive is a magazine about executives, their experience and their perspectives on the pharmaceutical industry. You have worked in Australia, Hong Kong and now you are the general manager of Malaysia, Singapore and Brunei. For the interest of our readers could you give an overview of what path you…
Sanofi Aventis France As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health care industry since it seems that the industrial aspects have been overlooked in recent years. I would also like to…
France What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that we can no longer live during this crisis without letting people express themselves genuinely. And I don’t mean expression of…
Sanofi Aventis South Korea You have been in S. Korea for a little over a year, following international assignments in Vietnam and Thailand. Besides the fact that this is a much bigger market, what is the major difference of the pharma industry in South Korea when compared to Southeast Asia? First of all, I…
See our Cookie Privacy Policy Here
